- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.05. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit | 2 | GlobeNewswire (USA) | ||
| 16.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Releases Virtual Investor "What This Means" Segment | 4 | GlobeNewswire (USA) | ||
| 04.04. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 04.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest ... | 178 | GlobeNewswire (Europe) | Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezolizumab (Tecentriq®) The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg in combination... ► Artikel lesen | |
| 01.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Announces Release of Corporate Update Video | 2 | GlobeNewswire (USA) | ||
| 01.04. | Sonnet BioTherapeutics ernennt Interims-CEO nach dem Tod des Gründers | 2 | Investing.com Deutsch | ||
| SONNET BIOTHERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 01.04. | Sonnet BioTherapeutics appoints interim CEO after founder's death | 3 | Investing.com | ||
| 01.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D. | 132 | GlobeNewswire (Europe) | PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted... ► Artikel lesen | |
| 26.03. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.03. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas | 155 | GlobeNewswire (Europe) | SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy... ► Artikel lesen | |
| 19.03. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 19.03. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant ... | 171 | GlobeNewswire (Europe) | Company advancing development of its modified version of Interleukin-18 (IL-18Binding Protein Resistant or IL-18BPR) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable... ► Artikel lesen | |
| 26.02. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors | 4 | GlobeNewswire (USA) | ||
| 26.02. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.02. | Sonnet BioTherapeutics advances novel ADC platform | 1 | Investing.com | ||
| 19.02. | Sonnet BioTherapeutics macht Fortschritte bei neuartiger ADC-Plattform | 1 | Investing.com Deutsch | ||
| 19.02. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline ... | 97 | GlobeNewswire (Europe) | Building on proven targeting of the FHAB domain, Sonnet's ADC platform offers flexible payload capacity and controllable drug-antibody ratios (DAR) An epidermal growth factor receptor 2 (HER2) ADC... ► Artikel lesen | |
| 13.02. | Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.02. | Sonnet BioTherapeutics reports wider Q1 net loss, CFO transition | 3 | Seeking Alpha | ||
| 13.02. | Sonnet BioTherapeutics ernennt neuen Chief Business Officer | 1 | Investing.com Deutsch |
Seite:
1 2 3 Weiter >>
60 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| KRAFT HEINZ | 24,960 | +0,08 % | Slideshow: New products from The Kraft Heinz Co., 3pm, LLC and Ferrero North America: New snack products are entering the category | ||
| BEYOND MEAT | 2,040 | +0,89 % | Beyond Meat, Inc.: Beyond Meat Reports First Quarter 2025 Financial Results | Company Reports Net Revenues Decline, Operating Expenses Reduction Announces $100 Million New Senior Secured Financing from Ahimsa Foundation Affiliate EL SEGUNDO, Calif., May 07, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| LUCKIN COFFEE | 28,600 | -1,38 % | Luckin Coffee Inc. Reveals Climb In Q4 Profit | BEIJING (dpa-AFX) - Luckin Coffee Inc. (LKNCY) reported a profit for its fourth quarter that increased from the same period last yearThe company's bottom line totaled RMB841.13 million, or RMB2.64... ► Artikel lesen | |
| SUNWIN STEVIA INTERNATIONAL | 0,014 | 0,00 % | SUNWIN STEVIA INTERNATIONAL, INC. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| YUM! BRANDS | 131,35 | +0,50 % | Yum! Brands: Yum!'s Packaging Has the Potential To Save Money and the Environment | NORTHAMPTON, MA / ACCESS Newswire / May 8, 2025 / Yum! BrandsKFC, Pizza Hut and Taco Bell are giving their packaging a second life in support of parent company Yum!'s commitment to making its consumer-facing... ► Artikel lesen | |
| CHIPOTLE MEXICAN GRILL | 43,950 | -0,51 % | Chipotle Mexican Grill, Inc.: Chipotle Names Jason Kidd Chief Operating Officer, President And Chief Strategy Officer Jack Hartung Sets Retirement Date | Kidd brings over 25 years of operations and retail experience to the company's Executive Committee
Hartung to step down as an executive officer to become a senior advisor for the company... ► Artikel lesen | |
| KROGER | 63,92 | +0,11 % | Alpha Modus Corp.: Alpha Modus Reaches Settlement Agreement with Kroger in Patent Litigation | CORNELIUS, N.C., May 05, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (Nasdaq: AMOD), a leader in AI-driven retail technology and intellectual property monetization, today announced that its... ► Artikel lesen | |
| OATLY GROUP | 9,040 | +1,35 % | Oatly veröffentlicht Finanzergebnisse für das erste Quartal und bleibt weiterhin auf Kurs für ein erstes volles Jahr mit profitablem Wachstum | ||
| DOMINOS PIZZA INC | 424,15 | -0,28 % | Analysts Increase Forecasts on Domino's Despite Revenue Miss. Should You Consider This Buffett Stock for Your Portfolio? | ||
| VILLAGE FARMS | 0,606 | +3,41 % | Village Farms Q1 Earnings Preview | ||
| BLENDER BITES | 0,164 | +36,25 % | Blender Bites Limited Provides Update On Default Announcement Pursuant To National Policy 12-203 - Management Cease Trade Orders | ||
| SWEETGREEN | 15,245 | -15,98 % | Stocks making the biggest moves midday: Insulet, Pinterest, Sweetgreen, Lyft, Microchip Technology and more | ||
| PORTILLOS | 11,240 | -1,58 % | Portillo's outlines plans for 12 new restaurants and targeted marketing campaigns in 2025 | ||
| CAVA GROUP | 94,04 | -2,01 % | Citi cuts CAVA stock price target to $114, maintains neutral rating | ||
| MCDONALDS | 279,20 | +0,20 % | DAX auf dem Weg zum Allzeithoch, Wall Street Schwung hält an, Freude auf Palantir, Microsoft, Meta, McDonalds | News von Trading-Treff.de Der DAX ist auf dem Weg zum Allzeithoch, der Wall Street Schwung hält an. Palantir, Microsoft, Meta, McDonalds, UBER Aktienanalyse im Video. Steigende Kurse zum Wochenstart... ► Artikel lesen |
Das Unternehmen SONNET BIOTHERAPEUTICS HOLDINGS INC kann der Branche Nahrungsmittel/Agrar zugeordnet werden. Der aktuelle Kurs liegt bei 1,280 Euro und damit -2,29 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONNET BIOTHERAPEUTICS HOLDINGS INC finden Sie auf Wallstreet Online.